Treace Medical Concepts announced it will highlight multiple new product innovations and present clinical data at the American Orthopaedic Foot & Ankle Society Annual Meeting in Seattle from September 16-19, 2026. The new offerings extend the company's bunion market leadership and accelerate penetration into new foot and ankle market adjacencies, according to CEO, Founder and Chairman John T. Treace. Among the featured technologies are the Lapiplasty Lightning System, the Tailorplasty MIS Tailor's Bunion System for minimally invasive treatment of tailor's bunions estimated to affect approximately 5-10% of the adult population, and the Treace X-ray App for radiographic measurements. New products aimed at the mid and hindfoot markets include SuperBite Fully-Threaded Compression Screws, the HyperPlate XM Dynamic Compression Locking Implant, CartiBlaster Powered Joint Prep instruments, and the VitaFuse Bioactive Glass Graft. Clinical results from the landmark 5-year ALIGN3D Lapiplasty, MTA3D Adductoplasty and SPRINT SpeedPlate studies will be presented during the meeting, with the ALIGN3D podium presentation set for Friday, September 18 at 8:45am PST by Daniel Farber, MD, of Lehigh Valley Orthopedic Institute.
Treace Medical Concepts IncTreace will unveil multiple new foot & ankle products and present 5-year clinical data at the 2026 AOFAS meeting, advancing its product pipeline.
Shanghai Henlius Biotech Inc
